NCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
Clinical Trials
1 trialsWithdrawn × Squamous Cell Carcinoma of Head and Neck × Electrophoresis, Polyacrylamide Gel × Clear all